Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib
Clinical trial NCT02297139 · COMPLETED
Trial details
- NCT number
- NCT02297139
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-31
- Primary completion
- 2022-05-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.